GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (LSE:HIK) » Definitions » 3-Year Dividend Growth Rate

Hikma Pharmaceuticals (LSE:HIK) 3-Year Dividend Growth Rate : 12.70% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Hikma Pharmaceuticals 3-Year Dividend Growth Rate?

Hikma Pharmaceuticals's Dividends per Share for the six months ended in Dec. 2023 was £0.20.

The historical rank and industry rank for Hikma Pharmaceuticals's 3-Year Dividend Growth Rate or its related term are showing as below:

LSE:HIK' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 8.9   Med: 15.7   Max: 38.4
Current: 12.7

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hikma Pharmaceuticals was 38.40% per year. The lowest was 8.90% per year. And the median was 15.70% per year.

LSE:HIK's 3-Year Dividend Growth Rate is ranked better than
58.7% of 322 companies
in the Drug Manufacturers industry
Industry Median: 9.25 vs LSE:HIK: 12.70

During the past 12 months, Hikma Pharmaceuticals's average Dividends Per Share Growth Rate was 12.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 12.70% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 11.70% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 15.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Hikma Pharmaceuticals's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.27. As of today, Hikma Pharmaceuticals's Dividend Yield % is 2.95%.

Good Sign:

Hikma Pharmaceuticals PLC stock dividend yield is close to 10-year high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Hikma Pharmaceuticals's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Hikma Pharmaceuticals's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hikma Pharmaceuticals's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hikma Pharmaceuticals's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Hikma Pharmaceuticals's 3-Year Dividend Growth Rate falls into.



Hikma Pharmaceuticals 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Hikma Pharmaceuticals  (LSE:HIK) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Hikma Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0.2/ 0.735
=0.27

During the past 13 years, the highest Dividend Payout Ratio of Hikma Pharmaceuticals was 0.32. The lowest was 0.13. And the median was 0.27.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Hikma Pharmaceuticals Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.4700002024-03-212024-03-222024-05-03Cash Dividendsemi-annuallyUSD:GBP 0.792000
GBP 0.1990002023-08-102023-08-112023-09-15Cash Dividendsemi-annuallyGBP:GBP 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Hikma Pharmaceuticals's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.57124/19.24
=2.97 %

Current Share Price is £19.24.
Hikma Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is £0.57124.

During the past 13 years, the highest Dividend Yield of Hikma Pharmaceuticals was 3.26%. The lowest was 0.51%. And the median was 1.41%.

Good Sign:

Hikma Pharmaceuticals PLC stock dividend yield is close to 10-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hikma Pharmaceuticals 3-Year Dividend Growth Rate Related Terms>


Hikma Pharmaceuticals (LSE:HIK) Business Description

Traded in Other Exchanges
Address
1 New Burlington Place, London, GBR, W1S 2HR
Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (LSE:HIK) Headlines

No Headlines